Matrix metalloproteinase-3 (MMP-3)-mediated gene therapy for glaucoma.

O'Callaghan J, Delaney C, O'Connor M, van Batenburg-Sherwood J, Schicht M, Lütjen-Drecoll E, Hudson N, Ni Dhubhghaill S, Humphries P, Stanley C, Keravala A, Chalberg T, Lawrence MS, Campbell M

Open source

DOI
10.1126/sciadv.adf6537
Published
2023 Apr 21
Container
Science advances
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1126/sciadv.adf6537,
  title = {Matrix metalloproteinase-3 (MMP-3)-mediated gene therapy for glaucoma.},
  author = {O'Callaghan J and Delaney C and O'Connor M and van Batenburg-Sherwood J and Schicht M and Lütjen-Drecoll E and Hudson N and Ni Dhubhghaill S and Humphries P and Stanley C and Keravala A and Chalberg T and Lawrence MS and Campbell M},
  year = {2023},
  journal = {Science advances},
  doi = {10.1126/sciadv.adf6537},
  url = {https://doi.org/10.1126/sciadv.adf6537}
}

RIS

TY  - JOUR
TI  - Matrix metalloproteinase-3 (MMP-3)-mediated gene therapy for glaucoma.
AU  - O'Callaghan J
AU  - Delaney C
AU  - O'Connor M
AU  - van Batenburg-Sherwood J
AU  - Schicht M
AU  - Lütjen-Drecoll E
AU  - Hudson N
AU  - Ni Dhubhghaill S
AU  - Humphries P
AU  - Stanley C
AU  - Keravala A
AU  - Chalberg T
AU  - Lawrence MS
AU  - Campbell M
PY  - 2023
JO  - Science advances
DO  - 10.1126/sciadv.adf6537
UR  - https://doi.org/10.1126/sciadv.adf6537
ER  - 

APA

J, O., C, D., M, O., J, V. B., M, S., E, L., N, H., S, N. D., P, H., C, S., A, K., T, C., MS, L., & M, C. (2023). Matrix metalloproteinase-3 (MMP-3)-mediated gene therapy for glaucoma.. Science advances. https://doi.org/10.1126/sciadv.adf6537

Source records